Literature DB >> 3926142

Fatal exacerbation of systemic lupus erythematosus after treatment with griseofulvin.

R Madhok, A Zoma, H Capell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926142      PMCID: PMC1416838          DOI: 10.1136/bmj.291.6490.249

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Lupus erythematosus in two patients after griseofulvin treatment of Trichophyton rubrum infection.

Authors:  S ALEXANDER
Journal:  Br J Dermatol       Date:  1962-02       Impact factor: 9.302

2.  Griseofulvin and lupus erythematosus.

Authors:  W A Anderson; D Torre
Journal:  J Med Soc N J       Date:  1966-05

3.  Lupus erythematosus exacerbated by griseofulvin.

Authors:  M S Watsky; Y L Lynfield
Journal:  Cutis       Date:  1976-02
  3 in total
  4 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

3.  Nephrotic syndrome related to systemic lupus erythematosus after griseofulvin therapy.

Authors:  M Bonilla-Felix; R Verani; L G Vanasse; A Hebert
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

4.  Developing a Continuous Quality Improvement Assessment Using a Patient-Centered Approach in Optimizing Systemic Lupus Erythematosus Disease Control.

Authors:  Katelyn Mariko Updyke; Brittany Urso; Shazia Beg; James Solomon
Journal:  Cureus       Date:  2017-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.